Similar articles

• New positive inotropic agents.

  Jafri SM, Bristol JA. Jafri SM, et al. Henry Ford Hosp Med J. 1986;34(3):188-92. Henry Ford Hosp Med J. 1986. PMID: 3542907 Review. No abstract available.
• [Positive inotropic agents in heart failure. Clinico-pharmacological evidence for medical practice].

  Rohde LE, Ribeiro JP. Rohde LE, et al. Arq Bras Cardiol. 1994 Dec;63(6):537-42. Arq Bras Cardiol. 1994. PMID: 7605243 Review. Portuguese. No abstract available.
• New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2.

  Colucci WS, Wright RF, Braunwald E. Colucci WS, et al. N Engl J Med. 1986 Feb 6;314(6):349-58. doi: 10.1056/NEJM198602063140605. N Engl J Med. 1986. PMID: 2418353 Review. No abstract available.
• Inotropic therapy of heart failure. Editorial comments on: Vasodilation and mechanoenergetic inefficiency dominates the effect of the "Ca2+ sensitizer" MCI-154 in intact pigs.

  Duncker DJ, Verdouw PD. Duncker DJ, et al. Scand Cardiovasc J. 2002 May;36(3):131-5. Scand Cardiovasc J. 2002. PMID: 12079634 Review. No abstract available.
• [Inotropic agents in advanced and refractory heart failure].

  Mangiavacchi M, Gronda E. Mangiavacchi M, et al. Ital Heart J Suppl. 2003 Jan;4(1):3-7. Ital Heart J Suppl. 2003. PMID: 12690928 Review. Italian. No abstract available.